CRC Tier 1 - Determining why mutations of the metabolic enzyme isocitrate dehydrogenase cause leukemias and brain cancers

Xiaoyan Jiang

Molecular Targeting of Critical Domains of AHI-1 Oncoprotein in Chronic Myeloid Leukemia Stem Cells Resistant to Current Tyrosine Kinase Inhibitor Therapy

Leukaemia

Aaron David Schimmer

Targeting the mitochondrial proteasome, ClpP, in AML

Leukaemia

Robert G Roeder

Transcriptional Regulatory Mechanisms in B Cell Development and Leukemogenesis

Leukaemia

Pediatric oncology or childhood cancer Hematology and hematologic malignancies Pathology

Peter Aplan

Activation of Proto-Oncogenes by Chromosomal Translocation

Leukaemia

Hematology and hematologic malignancies Pathology

James Kochenderfer

Autologous T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor

Leukaemia

Hematology and hematologic malignancies

Peter Stirling

Mechanisms of genome instability induced by RNA splicing defects

Leukaemia

Paul M Thompson

ENIGMA Center for Worldwide Medicine, Imaging & Genomics

Leukaemia

Tomasz Skorski

BCR/ABL-PI-3k-ROS pathway induce genomic instability ....

Leukaemia

Hematology and hematologic malignancies Pathology

H Leighton Grimes

Developing Novel STAT5 Protein Inhibitors for Treatment of Leukemias

Leukaemia

Hematology and hematologic malignancies Pathology